FDA Compounding Enforcement Under Fire from Lawmakers, Industry
Just three months after gaining new authority over compounders, the FDA is facing accusations from lawmakers and the compounding pharmacy lobby that it is overreaching its new role and retroactively applying a new federal law.
No comments:
Post a Comment